Form 4 for SCYX SCYNEXIS INC
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-04 · accession 0001209191-22-007727 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-08 | 2022-02-04 | SCYX | Angulo Gonzalez David | Chief Medical Off | A - Grant | $0.00 | +51.1K | 75.0K | +214% | $0 |
| D | 2022-02-08 | 2022-02-04 | SCYX | Angulo Gonzalez David | Chief Medical Off | A - Grant | $0.00 | +85.0K | 85.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-04 | A | A | 51,100 | $0.00 | 74,981 | D | — | — | (F1) Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-04 | A | A | 85,000 | $0.00 | 85,000 | D | $4.60 · — to 2032-02-03 | 85,000 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. |